3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
20
Completed
7
Recruiting
5
Active not recruiting
3
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
10
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Recurrence
2
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Adenocarcinoma
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Non-small Cell Lung Cancer
1
Small Cell Lung Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
HER2-positive Breast Cancer
1
Gastroesophageal Junction Cancer
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Advanced Solid Tumors
1
Advanced Pancreatic Cancer
1
Advanced Non-small Cell Lung Cancer
1
Advanced Non-Small Cell Lung Cancer
1
Advanced Malignant Neoplasm
1
Advanced Esophageal Carcinoma
1
Advanced Breast Cancer
1
Interventions
Cisplatin
11
toripalimab
8
Capecitabine
8
Gemcitabine
6
Fluorouracil
5
tislelizumab
4
Radiotherapy, Intensity-Modulated
4
Radiotherapy
3
sintilimab
2
anlotinib
2
Taxes
2
Radiation
2
Drug Therapy
2
spartalizumab
1
pembrolizumab
1
palbociclib
1
nedaplatin
1
lobaplatin
1
camrelizumab
1
Valganciclovir
1
Therapeutics
1
Taurine
1
Sodium Fluoride
1
Single Person
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Leyk
1
LY-2157299
1
Induction Chemotherapy
1
Docosahexaenoic Acids
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Nasopharyngeal Carcinoma
×
Docetaxel
×
Clear all
NCT03503136
2018-05-11
NX-NPC
Sun Yat-sen University
Phase 3
Not yet recruiting
632 enrolled